{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:19Z","timestamp":1787009959527,"version":"build-2736575974"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1097\/eja.0000000000000672","type":"journal-article","created":{"date-parts":[[2017,7,16]],"date-time":"2017-07-16T02:25:04Z","timestamp":1500171904000},"page":"641-649","source":"Crossref","is-referenced-by-count":75,"title":["Anaesthetic management of patients with myopathies"],"prefix":"10.1097","volume":"34","author":[{"given":"Mark","family":"Schieren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Defosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark U.","family":"Gerbershagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20200527","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R2-2-20200527","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1213\/01.ane.0000280935.90260.d0","article-title":"Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic","volume":"105","author":"Phadke","year":"2007","journal-title":"Anesth Analg"},{"key":"R3-2-20200527","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2003.08.008","article-title":"Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I","volume":"147","author":"Bhakta","year":"2004","journal-title":"Am Heart J"},{"key":"R4-2-20200527","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF03017922","article-title":"The anesthetic management of a patient with Emery\u2013Dreifuss muscular dystrophy for orthopedic surgery","volume":"49","author":"Aldwinckle","year":"2002","journal-title":"Can J Anaesth"},{"key":"R5-2-20200527","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, Part 2: Implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"R6-2-20200527","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1378\/chest.07-0458","article-title":"American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation","volume":"132","author":"Birnkrant","year":"2007","journal-title":"Chest"},{"key":"R7-2-20200527","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","article-title":"107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and mayotonic dystrophy. 7th\u20139th Juni 2002, Naarden, the Netherlands","volume":"13","author":"Bushby","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"R8-2-20200527","first-page":"34","article-title":"Preoperative risk assessment of children with Duchenne muscular dystrophy and relevance for anesthesia and intra- and postoperative course","volume":"91","author":"Wollinsky","year":"1996","journal-title":"Med Klin"},{"key":"R9-2-20200527","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2002-33028","article-title":"Respiratory muscle evaluation of the patient with neuromuscular disease","volume":"23","author":"DePalo","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"R10-2-20200527","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1378\/chest.90.1.52","article-title":"Detection of upper airway muscle involvement in neuromuscular disorders using the flow-volume loop","volume":"90","author":"Vincken","year":"1986","journal-title":"Chest"},{"key":"R11-2-20200527","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1378\/chest.85.6.792","article-title":"Atelectasis and neuromuscular respiratory failure","volume":"85","author":"Schmidt-Nowara","year":"1984","journal-title":"Chest"},{"key":"R12-2-20200527","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"R13-2-20200527","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10072-006-0701-0","article-title":"High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm","volume":"27","author":"Morandi","year":"2006","journal-title":"Neurol Sci"},{"key":"R14-2-20200527","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004150200010","article-title":"Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels","volume":"249","author":"Prelle","year":"2002","journal-title":"J Neurol"},{"key":"R15-2-20200527","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00131402-200212000-00004","article-title":"Current concepts in malignant hyperthermia","volume":"4","author":"Finsterer","year":"2002","journal-title":"J Clin Neuromuscul Dis"},{"key":"R16-2-20200527","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bja\/60.3.303","article-title":"Malignant hyperthermia: relationship to other diseases","volume":"60","author":"Brownell","year":"1988","journal-title":"Br J Anaesth"},{"key":"R17-2-20200527","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"R18-2-20200527","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"R19-2-20200527","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1213\/ANE.0b013e3181b5ae2d","article-title":"Core myopathies and risk of malignant hyperthermia","volume":"109","author":"Klingler","year":"2009","journal-title":"Anesth Analg"},{"key":"R20-2-20200527","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACO.0b013e3283393977","article-title":"Can inhalation agents be used in the presence of a child with myopathy?","volume":"23","author":"Veyckemans","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"R21-2-20200527","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1460-9592.2006.02105.x","article-title":"The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder","volume":"17","author":"Flick","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"R22-2-20200527","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00001503-200206000-00016","article-title":"Anesthesia and myopathy","volume":"15","author":"Baraka","year":"2002","journal-title":"Curr Opin Anaesthesiol"},{"key":"R23-2-20200527","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pan.13130","article-title":"Anesthesia-induced rhadbomyolysis or malignant hyperthermia: is defining the crisis important?","volume":"28","author":"Gray","year":"2017","journal-title":"Pediatr Anesth"},{"key":"R24-2-20200527","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00101-010-1794-7","article-title":"Anesthesia with neuromuscular diseases","volume":"59","author":"Gerbershagen","year":"2010","journal-title":"Anaesthesist"},{"key":"R25-2-20200527","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0002-9149(79)90459-4","article-title":"Cardiac conduction in the Kearns\u2013Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy). Report of 2 cases and review of 17 published cases","volume":"44","author":"Roberts","year":"1979","journal-title":"Am J Cardiol"},{"key":"R26-2-20200527","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2044.1994.tb04263.x","article-title":"Inhalation anaesthesia and the Kearns\u2013Sayre syndrome","volume":"49","author":"Lauwers","year":"1994","journal-title":"Anaesthesia"},{"key":"R27-2-20200527","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1991.00530180027012","article-title":"A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy","volume":"48","author":"Fenichel","year":"1991","journal-title":"Arch Neurol"},{"key":"R28-2-20200527","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/BRS.0b013e31814cf139","article-title":"Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis","volume":"32","author":"Shapiro","year":"2007","journal-title":"Spine"},{"key":"R29-2-20200527","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ACO.0b013e328337ffe0","article-title":"Anesthesia for patients with a history of malignant hyperthermia","volume":"23","author":"Wappler","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"R30-2-20200527","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ALN.0b013e3181ee2cb7","article-title":"Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice","volume":"114","author":"Kim","year":"2011","journal-title":"Anesthesiology"},{"key":"R31-2-20200527","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF03010977","article-title":"Duchenne muscular dystrophy and malignant hyperthermia \u2013 two case reports","volume":"33","author":"Wang","year":"1986","journal-title":"Can Anaesth Soc J"},{"key":"R32-2-20200527","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/aas.12541","article-title":"Malignant hyperthermia, a Scandinavian update","volume":"59","author":"Broman","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"R33-2-20200527","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene \u2013 a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"R34-2-20200527","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-198609000-00012","article-title":"Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia","volume":"65","author":"Watson","year":"1986","journal-title":"Anesthesiology"},{"key":"R35-2-20200527","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1460-9592.2007.02302.x","article-title":"Duchenne muscular dystrophy: an old anesthesia problem revisited","volume":"18","author":"Hayes","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"R36-2-20200527","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/pan.12120","article-title":"Myotonic dystrophies type 1 and 2: anesthetic care","volume":"23","author":"Veyckemans","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R37-2-20200527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9592.2006.02106.x","article-title":"Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child","volume":"17","author":"Allison","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"R38-2-20200527","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACO.0b013e3282f82bcc","article-title":"Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?","volume":"21","author":"Driessen","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"R39-2-20200527","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2044.1989.tb11182.x","article-title":"Malignant hyperthermia and myotonia congenita (Thomsen's disease)","volume":"44","author":"Haberer","year":"1989","journal-title":"Anaesthesia"},{"key":"R40-2-20200527","first-page":"295","article-title":"Malignant hyperthermia in paramyotonia congenita","volume":"13","author":"Thomas","year":"1988","journal-title":"Anaesthesiol Reanim"},{"key":"R41-2-20200527","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1460-9592.1998.00725.x","article-title":"Anaesthesia and mitochondrial disease","volume":"8","author":"Wallace","year":"1998","journal-title":"Paediatr Anaesth"},{"key":"R42-2-20200527","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1460-9592.2009.03011.x","article-title":"A disquisition on sleep-disordered breathing in children","volume":"19","author":"Lerman","year":"2009","journal-title":"Paediatr Anaesth"},{"key":"R43-2-20200527","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ACO.0b013e32811e16e7","article-title":"Inhalation agents in pediatric anaesthesia \u2013 an update","volume":"20","author":"Lerman","year":"2007","journal-title":"Curr Opin Anaesthesiol"},{"key":"R44-2-20200527","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1213\/00000539-199908000-00017","article-title":"Mivacurium for muscle relaxation in a child with Duchenne's muscular dystrophy","volume":"89","author":"Uslu","year":"1999","journal-title":"Anesth Analg"},{"key":"R45-2-20200527","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bja\/aei249","article-title":"Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy","volume":"95","author":"Schmidt","year":"2005","journal-title":"Br J Anaesth"},{"key":"R46-2-20200527","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1213\/01.ANE.0000140783.39597.FD","article-title":"Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy","volume":"100","author":"Caron","year":"2005","journal-title":"Anesth Analg"},{"key":"R47-2-20200527","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1460-9592.2006.01870.x","article-title":"Rocuronium 0.3\u200amg\u200a\u00d7\u200akg\u22121 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy","volume":"16","author":"Muenster","year":"2006","journal-title":"Paediatr Anaesth"},{"key":"R48-2-20200527","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1460-9592.2009.03178.x","article-title":"Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy","volume":"19","author":"de Boer","year":"2009","journal-title":"Paediatr Anaesth"},{"key":"R49-2-20200527","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/bja\/aep093","article-title":"Reversal of neuromuscular block","volume":"103","author":"Srivastava","year":"2009","journal-title":"Br J Anaesth"},{"key":"R50-2-20200527","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/bja\/54.5.529","article-title":"Hazards of neostigmine in patients with neuromuscular disorders","volume":"54","author":"Buzello","year":"1982","journal-title":"Br J Anaesth"},{"key":"R51-2-20200527","first-page":"959","article-title":"Rocuronium and sugammadex in myotonic dystrophy","volume":"38","author":"Baumgartner","year":"2010","journal-title":"Anaesth Intensive Care"},{"key":"R52-2-20200527","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1460-9592.2005.01583.x","article-title":"Resistance to cisatracurium in a patient with MELAS syndrome","volume":"15","author":"Aouad","year":"2005","journal-title":"Paediatr Anaesth"},{"key":"R53-2-20200527","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00000542-200305000-00005","article-title":"Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial","volume":"98","author":"Mencke","year":"2003","journal-title":"Anesthesiology"},{"key":"R54-2-20200527","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/aep124","article-title":"Avoidance of neuromuscular blocking agents may increase the risk of difficult tracheal intubation: a cohort study of 103,812 consecutive adult patients recorded in the Danish Anaesthesia Database","volume":"103","author":"Lundstrom","year":"2009","journal-title":"Br J Anaesth"},{"key":"R55-2-20200527","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/bja\/aem147","article-title":"Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort","volume":"99","author":"Combes","year":"2007","journal-title":"Br J Anaesth"},{"key":"R56-2-20200527","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/bja\/aei006","article-title":"Tracheal intubation without the use of neuromuscular blocking agents","volume":"94","author":"Woods","year":"2005","journal-title":"Br J Anaesth"},{"key":"R57-2-20200527","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1460-9592.2002.00727.x","article-title":"A survey of tracheal intubation without muscle relaxant in paediatric patients","volume":"12","author":"Simon","year":"2002","journal-title":"Paediatr Anaesth"},{"key":"R58-2-20200527","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00101-015-0075-x","article-title":"Characteristics of anesthesia in patients with MELAS syndrome: case report of anesthesia in video-assisted thoracoscopy","volume":"64","author":"Haas","year":"2015","journal-title":"Anaesthesist"},{"key":"R59-2-20200527","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2003-40078","article-title":"Current aspects of anesthesia in neuromuscular diseases","volume":"38","author":"Wappler","year":"2003","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"R60-2-20200527","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1460-9592.2005.01801.x","article-title":"Muscular dystrophy, anesthesia and the safety of inhalational agents revisited; again","volume":"16","author":"Yemen","year":"2006","journal-title":"Paediatr Anaesth"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000000672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:44:51Z","timestamp":1719312291000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003643-201710000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000000672","relation":{},"ISSN":["0265-0215"],"issn-type":[{"value":"0265-0215","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}